National Biologics Facility

The National Biologics Facility offers custom manufacturing solutions for the development and production of the next generation of biological therapeutics. Combining extensive expertise and from state-of-the-art laboratories, the NBF provides the necessary infrastructure to bridge the gap between laboratory experiments and production of material for translation through pre-clinical and clinical trials. The facility staff of scientists and bioprocess engineers offer world-class expertise in molecular biology, antibody engineering (including phage display), mammalian cell culture and biopharmaceutical development.

Founded in 2007, the NBF was established to facilitate biotechnology companies and academic researchers in developing and validating biologics as an exciting and rapidly expanding class of human therapeutics. 

Today, the NBF operates two nodes; one at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland, and a second, at the CSIRO Molecular Health Technologies in Melbourne. Each node offers unique infrastructure and services and together, work to enhance capabilities in early stage biologics technology in Australia. 

Queensland node

Contact:  Dr Martina Jones

Email:  martina.jones@uq.edu.au

Phone:  +61 7 3346 3178

Victoria node

Contact:  Prof George Lovrecz

Email:  george.lovrecz@csiro.au 

Phone:  +61 (0)3 9662 7348

Level 14, 330 Collins St

Melbourne 3000 VIC

Call

T: +61 (07) 3735 4433

©2019 Therapeutic Innovation Australia

Enabled by

NCRIS-PROVIDER-RGB-REV.png